TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q2 2025 · 200 positions · Total reported value $1.98B · Top-10 concentration 35.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 200 equity positions with a combined reported value of $1.98B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q2 2025 were LKFT ($111.68M), TARS ($99.44M), AUPH ($84.95M). By sector, the heaviest allocations are Health Care 74.9%, Industrials 2.6%. Versus the prior quarter, allocation shifted toward Industrials (+2.2pp), Health Care (+2.0pp) and away from Other (-3.9pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 83% of names.

The largest new positions opened in Q2 2025 were MTD ($22.91M), URGN ($13.70M), TVTX ($10.36M).

Of the 1 positions fully exited versus the prior quarter, the largest were ITCI ($29.02M), SLRN ($24.25M), ONC ($10.07M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • MTD METTLER TOLEDO INTERNATIONAL · $22.91M
  • URGN UROGEN PHARMA LTD · $13.70M
  • TVTX TRAVERE THERAPEUTICS INC · $10.36M
  • WGS GENEDX HOLDINGS CORP · $9.23M
  • LLY ELI LILLY & CO · $7.80M
  • SRPT SAREPTA THERAPEUTICS INC · $7.19M
  • ALMS ALUMIS INC · $5.99M
  • SMMT SUMMIT THERAPEUTICS INC · $5.32M

Fully Exited (vs previous quarter)

  • ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $29.02M
  • SLRN ACELYRIN INC · prev qtr: $24.25M
  • ONC BEONE MEDICINES LTD · prev qtr: $10.07M
  • CRSP CRISPR THERAPEUTICS AG · prev qtr: $9.07M
  • PHAT PHATHOM PHARMACEUTICALS INC · prev qtr: $7.52M
  • VIR VIR BIOTECHNOLOGY INC · prev qtr: $3.24M
  • ALLK ALLAKOS INC · prev qtr: $1.98M
  • BLUE BLUEBIRD BIO INC · prev qtr: $1.95M

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 74.9%
Technology 2.4%
Financials 0.2%
Other 18.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.99M $111.68M 5.64%
5.64%
Add
2 2.45M $99.44M 5.03%
5.03%
Hold
3 10.03M $84.95M 4.29%
4.29%
Hold
4 2.11M $66.07M 3.34%
3.34%
Add
5 2.33M $64.43M 3.26%
3.26%
Add
6 1.24M $62.90M 3.18%
3.18%
Hold
7 4.94M $55.87M 2.82%
2.82%
Hold
8 1.10M $53.72M 2.72%
2.72%
Add
9 3.20M $47.90M 2.42%
2.42%
Add
10 5.00M $46.03M 2.33%
2.33%
Hold
11 2.84M $39.74M 2.01%
2.01%
Add
12 3.83M $38.15M 1.93%
1.93%
Add
13 13.50M $35.09M 1.77%
1.77%
Add
14 1.50M $32.35M 1.64%
1.64%
Hold
15 1.35M $31.81M 1.61%
1.61%
Add
16 600.00K $31.56M 1.59%
1.59%
Add
17 3.20M $29.73M 1.50%
1.50%
Add
18 1.33M $29.55M 1.49%
1.49%
Reduce
19 830.00K $29.46M 1.49%
1.49%
Hold
20 270.00K $28.75M 1.45%
1.45%
Hold
21 8.07M $27.92M 1.41%
1.41%
Hold
22 897.62K $26.31M 1.33%
1.33%
Add
23 11.07M $25.12M 1.27%
1.27%
Add
24 19.50K $22.91M 1.16%
1.16%
New
25 105.66K $22.14M 1.12%
1.12%
Add
26 317.50K $20.72M 1.05%
1.05%
Hold
27 130.51K $20.62M 1.04%
1.04%
Reduce
28 190.00K $20.16M 1.02%
1.02%
Hold
29 200.00K $20.13M 1.02%
1.02%
Add
30 1.95M $19.34M 0.98%
0.98%
Reduce
31 26.01K $19.20M 0.97%
0.97%
Reduce
32 1.05M $19.12M 0.97%
0.97%
Hold
33 1.42M $18.94M 0.96%
0.96%
Add
34 150.00K $18.85M 0.95%
0.95%
Hold
35 2.10M $18.56M 0.94%
0.94%
Hold
36 4.89M $17.60M 0.89%
0.89%
Add
37 400.00K $15.36M 0.78%
0.78%
Hold
38 1.83M $15.35M 0.78%
0.78%
Hold
39 1.14M $14.25M 0.72%
0.72%
Reduce
40 1.10M $13.80M 0.70%
0.70%
Hold
41 1.00M $13.70M 0.69%
0.69%
New
42 1.85M $13.32M 0.67%
0.67%
Hold
43 3.06M $12.61M 0.64%
0.64%
Hold
44 1.40M $12.19M 0.62%
0.62%
Hold
45 7.06M $11.71M 0.59%
0.59%
Hold
46 800.10K $11.43M 0.58%
0.58%
Hold
47 2.35M $11.11M 0.56%
0.56%
Hold
48 2.75M $10.64M 0.54%
0.54%
Hold
49 150.00K $10.48M 0.53%
0.53%
Reduce
50 700.00K $10.36M 0.52%
0.52%
New

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, TANG CAPITAL MANAGEMENT LLC reported 200 equity positions worth $1.98B in aggregate; its largest disclosed positions were LKFT ($111.68M), TARS ($99.44M), AUPH ($84.95M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $1.98B of long equity holdings across 200 positions as of 2025-Q2. Top-10 holdings account for 35.0% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →